Uganda - English - National Drug Authority

gufic biosciences ltd - vancomycinhydrochloride - parenteral ordinary dry vials - 1g/vial

United States - English - NLM (National Library of Medicine)

alvogen inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 125 mg - vancomycin hydrochloride capsules are indicated for the treatment of clostridioides difficile -associated diarrhea. vancomycin hydrochloride capsules are also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients lessthan 18 years of age. limitations of use • parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. • orally administered vancomycin hydrochloride capsules are not effective for other types ofinfections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considere

United States - English - NLM (National Library of Medicine)

orient pharma co.,ltd yunlin plant - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride capsules are indicated for the treatment of c. difficile -associated diarrhea. vancomycin hydrochloride capsules is also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains). in adult and pediatric patients less than 18 years of age. limitations of use - parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. - orally administered vancomycin hydrochloride capsules is not effective for other types of infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered i

United States - English - NLM (National Library of Medicine)

pai holdings, llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride capsules are indicated for the treatment of c. difficile-associated diarrhea. vancomycin hydrochloride capsules are also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. limitations of use • parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. • orally administered vancomycin hydrochloride capsules is not effective for other types of infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selectin

United States - English - NLM (National Library of Medicine)

pai holdings, llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride capsules are indicated for the treatment of c. difficile -associated diarrhea. vancomycin hydrochloride capsules is also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains). parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. orally administered vancomycin hydrochloride capsules is not effective for other types of infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibact

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride capsules are indicated for the treatment of c. difficile -associated diarrhea. vancomycin hydrochloride capsules is also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains). parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections. orally administered vancomycin hydrochloride capsules is not effective for other types of infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in s